Drugs / BIO MTA+
last change Jul 2025 re-read 3 minutes ago

BIO MTA+

Developed for
pulpitis
Investigated by
TC Erciyes University

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06784622 Feb → Jun 2025 overdue pulpitis TC Erciyes University Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BIO MTA+ “partial and total pulpotomy with mineral trioxide aggregate (BIO MTA+) and bioceramic sealer (Well Root PT) in terms of pain and vitality in permanent molars with exposed pulp...” NCT06784622 ↗